Literature DB >> 3444481

The effect of kinin agonists and antagonists on the pain response of the human blister base.

E T Whalley1, S Clegg, J M Stewart, R J Vavrek.   

Abstract

1. The effect of bradykinin (BK) and some analogues of BK on the human blister base was studied. 2. BK produced reproducible dose-related increases in pain responses. A characteristic delay, which was not dose-related occurred between application of BK and the resultant response. 3. The rank order of potency of several kinin analogues on the pain response was BK much much greater than sigma-cyclo-(Lys1-Gly6)-BK = sigma-cyclo-kallidin greater than des-Arg9-BK. 4. No increase in pain response was seen with repeated application of the selective B1 receptor agonist des-Arg9-BK to the same blister base at 4 h intervals. The B1 receptor antagonist des-Arg9-Leu8-BK was without effect against BK-induced responses. 5. The B2 receptor antagonists, D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Phe-Thi-Arg-TEA and D-Pro-Phe-Arg-heptylamide produced significant antagonism of the bradykinin-induced pain responses at doses which had no effect against 5-hydroxytryptamine or potassium chloride. 6. It is concluded that the kinin receptor mediating pain on the human blister base is of the B2 type.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3444481     DOI: 10.1007/BF00165756

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  17 in total

1.  Pain-producing substance in human inflammatory exudates and plasma.

Authors:  D ARMSTRONG; J B JEPSON; C A KEELE; J W STEWART
Journal:  J Physiol       Date:  1957-02-15       Impact factor: 5.182

2.  Observations on chemical excitants of cutaneous pain in man.

Authors:  D ARMSTRONG; R M L DRY; C A KEELE; J W MARKHAM
Journal:  J Physiol       Date:  1953-05-28       Impact factor: 5.182

3.  Chemical irritant algesia assessed using the human blister base.

Authors:  R W Foster; Kathleen M Weston
Journal:  Pain       Date:  1986-05       Impact factor: 6.961

Review 4.  Pharmacology of kinins: their relevance to tissue injury and inflammation.

Authors:  F Marceau; A Lussier; D Regoli; J P Giroud
Journal:  Gen Pharmacol       Date:  1983

5.  Selective activity of cyclokinins.

Authors:  C F Spraggs; H S Margolius; A W Cuthbert
Journal:  J Pharm Pharmacol       Date:  1983-04       Impact factor: 3.765

6.  Antagonism of the bradykinin induced contractile response of isolated smooth muscle preparations by low molecular weight synthetic chromogenic peptide substrates for serine proteases.

Authors:  J Fareed; G Kindel; H L Messmore; J U Balis
Journal:  Adv Biosci       Date:  1978-07-22

7.  De novo formation of vascular receptors for bradykinin.

Authors:  D Regoli; F Marceau; J Barabé
Journal:  Can J Physiol Pharmacol       Date:  1978-08       Impact factor: 2.273

Review 8.  Pharmacology of bradykinin and related kinins.

Authors:  D Regoli; J Barabé
Journal:  Pharmacol Rev       Date:  1980-03       Impact factor: 25.468

9.  Induction of beta 1-receptors for kinins in the rabbit by a bacterial lipopolysaccharide.

Authors:  D C Regoli; F Marceau; J Lavigne
Journal:  Eur J Pharmacol       Date:  1981-04-24       Impact factor: 4.432

10.  Receptors mediating the increase in vascular permeability to kinins: comparative studies in rat, guinea-pig and rabbit.

Authors:  E T Whalley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

View more
  19 in total

Review 1.  Novel pharmacological strategies for analgesia.

Authors:  M Perkins; A Dray
Journal:  Ann Rheum Dis       Date:  1996-10       Impact factor: 19.103

2.  Inhibition of bradykinin-induced bronchoconstriction in the guinea-pig by a synthetic B2 receptor antagonist.

Authors:  L S Jin; E Seeds; C P Page; M Schachter
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

3.  Bradykinin B1 and B2 receptors, tumour necrosis factor alpha and inflammatory hyperalgesia.

Authors:  S Poole; B B Lorenzetti; J M Cunha; F Q Cunha; S H Ferreira
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

4.  Evaluation of cutaneous algogenic responses to bradykinin and inhibition by bradykinin analogs.

Authors:  B K Schneider; J G Morelli; R J Vavrek; J M Stewart; W L Weston
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

5.  Bradykinin initiates cytokine-mediated inflammatory hyperalgesia.

Authors:  S H Ferreira; B B Lorenzetti; S Poole
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

6.  Induction of bradykinin B1 receptors in vivo in a model of ultra-violet irradiation-induced thermal hyperalgesia in the rat.

Authors:  M N Perkins; D Kelly
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

7.  Influence of bradykinin in gastrointestinal disorders and visceral pain induced by acute or chronic inflammation in rats.

Authors:  V Julia; T Mezzasalma; L Buéno
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

8.  Evidence for a role of bradykinin in experimental pain models.

Authors:  T T Chau; A C Lewin; T L Walter; R P Carlson; B M Weichman
Journal:  Agents Actions       Date:  1991-09

Review 9.  Serotonergic neuromodulation of peripheral nociceptors.

Authors:  Dayna R Loyd; Michael A Henry; Kenneth M Hargreaves
Journal:  Semin Cell Dev Biol       Date:  2012-09-19       Impact factor: 7.727

10.  Activation of mechanonociceptors by pro-inflammatory peptides melittin and PLAP peptide.

Authors:  B Cooper; J S Bomalaski
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.